CN

Newsroom

Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...

Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya

2022-12-23

On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...

see details 》

Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s Intern...

Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout

2022-11-09

On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...

see details 》

Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts Intern...

Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts International Clinical Trial

2022-11-09

Source: Xinhua News Agency The launch ceremony of the international clinical trial of the Recombinant COVID-19 Omicron-Delta Variant Vaccin...

see details 》